16-172908-CCA-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 0P and 0B.
The NM_000517.6(HBA2):c.-3_-2delAC variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000517.6 5_prime_UTR
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HBA2 | ENST00000251595 | c.-3_-2delAC | 5_prime_UTR_variant | Exon 1 of 3 | 1 | NM_000517.6 | ENSP00000251595.6 | |||
HBA2 | ENST00000482565.1 | n.17_18delAC | non_coding_transcript_exon_variant | Exon 1 of 2 | 1 | |||||
HBA2 | ENST00000397806 | c.-50_-49delAC | 5_prime_UTR_variant | Exon 1 of 3 | 2 | ENSP00000380908.1 | ||||
HBA2 | ENST00000484216.1 | c.-37_-36delCA | upstream_gene_variant | 1 | ENSP00000495899.1 |
Frequencies
GnomAD3 genomes Cov.: 0
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000390 AC: 1AN: 256564Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 136934
GnomAD4 genome Cov.: 0
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant summary: HBA2 c.-3_-2delAC is located in the untranslated mRNA region upstream of the initiation codon. Consensus agreement among computation tools predict no significant impact on normal splicing. At least one study showed this variant did not affect mRNA splicing (Morle_1985). The variant was absent in 53060 control chromosomes (gnomAD). c.-3_-2delAC has been reported in the literature in one individual affected with Alpha Thalassemia (Morle_1985). These data indicate that the variant may be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function and this variant leads to a 30-45% reduction in translation efficiency in vitro (Morle_1986). The following publications have been ascertained in the context of this evaluation (PMID: 4006915, 3703675). No submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at